CAG
BOUT icon

Csenge Advisory Group’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Csenge Advisory Group’s Portfolio BOUT Stock Details BOUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,585
Closed -$250K – 581
2022
Q1 		$250K Buy
+6,585
New +$241K 0.02% 542

Other funds holding BOUT

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
PFGIA
Patriot Financial Group Insurance Agency Westborough, Massachusetts $974M AUM 29.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.43B AUM 22.07% 1-Year Est. Return
AIP
Ahrens Investment Partners Lafayette, Louisiana $202M AUM 3.91% 1-Year Est. Return

Csenge Advisory Group's BOUT Position: Q2 2022 in Review

Csenge Advisory Group sold out of CapForce IBD Breakout Opportunities ETF (BOUT) in Q2 2022, closing a stake of 6,585 shares — an estimated $250K sold.

Csenge Advisory Group first reported a position in BOUT in Q1 2022 and held it in 1 quarter. The position peaked at $250K in Q1 2022. 13 funds tracked by Wall St. Rank hold BOUT as of Q2 2022.

  • Csenge Advisory Group reported no remaining CapForce IBD Breakout Opportunities ETF position as of Q2 2022 after selling out during the quarter.
  • Csenge Advisory Group sold 6,585 CapForce IBD Breakout Opportunities ETF shares in Q2 2022, an estimated $250K.
  • Csenge Advisory Group first reported a position in CapForce IBD Breakout Opportunities ETF in Q1 2022 and held it in 1 quarter.
  • Csenge Advisory Group's CapForce IBD Breakout Opportunities ETF position peaked at $250K in Q1 2022.
  • 13 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q2 2022.

Based on Csenge Advisory Group's 13F filing for Q2 2022, filed 27 Jul 2022.